Healthcare -
Biotechnology - NASDAQ - US
$ 1.5049
13.2 %
$ 106 M
Market Cap
-2.25
P/E
SLS - CASH & EQUIVALENTS
Cash & Equivalents SLS - SELLAS Life Sciences Group, Inc.
2.53 M
LAST VALUE
-65.58%
2 YEAR CAGR
-13.87%
5 YEAR CAGR
-25.46%
10 YEAR CAGR